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Abstract A son1 mutant was isolated as a mutant showing
synthetic lethality with nin1-1 which is defective in the p31
component of the regulatory subunit of the yeast 26S protea-
some. son1v showed a synthetic effect with sen3v and sun1v,
both components of the 26S proteasome, and with cdc28-1N. The
26S proteasome was partially purified from the wild type yeast.
The FPLC fractions were analyzed by Western blotting using
anti-Son1p antibody and antibodies against some authentic
subunits of the 26S proteasome, and we found that Son1p co-
migrated with components of the 26S proteasome. The 26S
proteasome containing fraction was immunoprecipitated with
anti-Son1p antibody. The resultant precipitate contained Nin1p,
Sun1p, TBP1, and the 20S proteasome. Combining genetic and
biochemical results together, we concluded that Son1p is a
component of the yeast 26S proteasome.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Accumulating evidence indicates that proteolysis by the
ubiquitin-proteasome system plays pivotal roles in many cel-
lular processes. Key factors of cell cycle regulation, such as
cyclins for example, are degraded by the ubiquitin-proteasome
pathway [1]. The machinery for the degradation in this system
is the 26S proteasome, an ATP-dependent, multicatalytic pro-
tease of 2000 kDa [2^4]. The 26S proteasome is composed of
two subcomplexes, the 20S proteasome and regulatory com-
ponents. The 20S proteasome is a catalytic core and is con-
sisted of seven structurally related polypeptides designated K
subunits and seven structurally related L subunits, which are
assembled into a cylinder-like structure [5]. The regulatory
component contains six ATPases and an unknown number
of non-ATPase subunits [5,6]. Our major concern is how the
activity of the 26S proteasome is regulated. To this goal it is
necessary to know the subunit composition of the regulatory
component. Attempts to elucidate the composition of subunits
of the regulatory component have been conducted and the
results indicated, fortunately, that many of the subunits are
highly conserved among eukaryotes [7]: Sen3p/p112 [8,9],
Nas1p/p97 [10], etc.
Genes encoding subunits of the yeast 20S proteasome have
been completely elucidated: seven genes for the K subunits
and seven genes for the L subunits, all of which are essential
except y13/PRE9 for an K subunit [11]. On the other hand,
subunits of the regulatory component are not yet completely
known. cim3/sug1/p45 and cim5 were identi¢ed as mutants
that showed synthetic lethality with cdc28-1N and were shown
to be ATPases contained in the regulatory component [12].
sug2, like sug1, was ¢rst isolated as a suppressor of gal4 and
later identi¢ed as the yeast 26S proteasome subunit [13]. Other
ATPase subunits were identi¢ed as homologues of the mam-
malian counterparts [14]. In a previous study, we obtained a
temperature sensitive mutant nin1-1 which has a defect in a
subunit of the regulatory component, a counterpart of p31 of
the human proteasome [15^17]. We also reported two multi-
copy suppressors of nin1-1, both of which encode a compo-
nent of the regulatory subunit, SUN1 and SUN2 [18,19].
Sun1p is a homologue of S5a multiubiquitin binding protein
and Sun2p is a homologue of p58 of the human proteasome
subunit. In this communication, we describe the isolation of a
son1 mutant by exploiting the adenine color assay method [20]
for screening of a synthetically lethal mutation with nin1-1
and show that Son1p is a component of the yeast 26S protea-
some. A son1 mutation was ¢rst identi¢ed as a suppressor of
the sec63-101 mutation [21]. Another son1 allele was found in
the ufd (ubiquitin fusion degradation) mutations which had
been screened for mutants defective in degradation of ubiq-
uitin-L-galactosidase fusion protein [22]. The son1 and sen3
mutants were isolated as suppressors of the mating defect
shown by the gpa1val50 mutant [23].
2. Materials and methods
2.1. Strains, media, and genetic analysis
The Saccharomyces cerevisiae strains used in this study are listed in
Table 1. Mutants isolated in this study were also used as described in
the text. Escherichia coli strain DH1 (endA1 gyrA96 hsdR17 recA1
relA1 supE44 thi-1 F3) was used for propagation and construction of
plasmids. YPD, YPGal, SD, omission media and sporulation medium
were for yeast and prepared as described previously [24]. A permissive
temperature for yeast was 25‡C and a non-permissive temperature was
35^37‡C depending on the mutant strains. E. coli was grown at 37‡C
in LB [25] supplemented with 50 Wg/ml ampicillin as appropriate.
Methods for yeast genetics were described previously [24].
2.2. Construction of pDL120 (URA3-ade3-2p-CEN4-ARS1)
First, a leaky ade3 mutant gene, ade3-2p described by Koshland et
al. [20], was integrated into a CEN plasmid, YCp50 [26]. The 4.5 kbp
SalI-SmaI fragment containing the ade3-2p gene was blunt ended and
then ligated into the SmaI site of YCp50. The resulting plasmid was
designated pKOM3. The 2 kbp SalI fragment containing the NIN1
gene was excised form pHN4 [15] and inserted into the SalI site of
pKOM3, resulting in pDL120.
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2.3. Biochemical analysis
The yeast 26S proteasome was partially puri¢ed according to the
procedure described by Rubin et al. [27]. Yeast extract was prepared
from W303D cells grown in 400 ml YPD at 25‡C for 36 h with
shaking. Cells were harvested by centrifugation (5000Ug) for 5 min,
resuspended in 6 ml bu¡er A (100 mM Tris-HCl, pH 7.6, 2 mM ATP,
2 mM MgCl2, 0.5 mM EDTA, 1 mM DTT, 2% glycerol), and then
disrupted by vortexing with glass beads (0.5 mm in diameter) at the
maximum speed for 20 min at 4‡C with occasional cooling. Debris
was removed by centrifugation at 15 000Ug for 15 min at 4‡C and the
resultant supernatant was subjected to high speed centrifugation at
100 000Ug for 20 min at 4‡C and then at 300 000Ug for 3 h at 4‡C.
Precipitate was dissolved in 500 Wl bu¡er B (100 mM NaH2PO4/
NaOH, pH 6.5, 1 mM ATP, 1 mM MgCl2, 0.1 mM EDTA, 1 mM
DTT, 10% glycerol) and loaded on a phosphocellulose column (1.5 cm
in diameterU4 cm; bed volume, 8 ml) equilibrated with bu¡er B.
Elution was conducted with bu¡er B at a £ow speed of 0.6 ml/min
and 0.6 ml was collected in each fraction. The £ow through fractions
(1.2 ml) containing the 26S proteasome were pooled and ¢ltered
through a membrane ¢lter (pore size, 0.45 Wm), applied to a Superose
6 column equilibrated with bu¡er C (20 mM Tris-HCl, pH 7.8, 1 mM
ATP, 2 mM MgCl2, 0.1 mM EDTA, 1 mM DTT, 0.1 M NaCl, 10%
glycerol) and FPLC was performed. Each fraction (0.5 ml) was eluted
with bu¡er C at a £ow speed of 0.25 ml/min. Protease activity was
assayed by using Suc-LLVY-MCA as substrate with or without ATP
and 0.1% SDS to discriminate protease activity of the 26S proteasome
from that of the 20S proteasome. Western blot analysis was carried
out as described previously [17]. Protein concentration was deter-
mined by the method described by Bradford [28]. SDS-PAGE was
performed by the Laemmli system [29].
2.4. Antibodies
Anti-Son1p peptide antibody was prepared as described previously.
In brief, a peptide consisted of 18 amino acid residues (494^511 in the
amino acid sequence of Son1p) was chemically synthesized and a
cysteine residue was attached at the C terminus. The peptide was
conjugated to keyhole limpet hemocyanin and the resulting conjugates
emulsi¢ed with complete Freund adjuvant were injected to rabbits to
raise antibodies. Anti-TBP1 antibodies [17], anti-Sun1p antibodies
[19], anti-p45 antibodies [10] and anti-20S proteasome antibodies
[30] were described previously.
2.5. Immunoprecipitation
Polyclonal antibodies against Son1p and non-immune rabbit IgG
(60 Wg each in 40 Wl of bu¡er D which is bu¡er A lacking DTT) were
mixed with protein A-Sepharose beads (Pharmacia) and mixtures were
rotated at 4‡C for 2 h. The beads were then treated with 1% skimmed
milk in bu¡er D, washed three times with bu¡er D, and added to 20
Wl of the 26S proteasome-containing fraction obtained from the
Superose 6 column. After the mixtures were rotated at 4‡C for 2 h,
supernatant (40 Wl) was recovered by centrifugation and mixed with
sample bu¡er (20 Wl) for SDS-PAGE, while the resulting beads were
washed three times with bu¡er D and suspended in the sample bu¡er
(60 Wl). 20 Wl each of supernatant and beads suspension were sub-
jected to SDS-PAGE in a slab gel containing 12.5% polyacrylamide
followed by Western blot analysis.
2.6. Determination of nucleotide sequence
Nucleotide sequences were determined by the dideoxy chain termi-
nation method described by Sanger et al. [31], using a DNA sequencer
Model 373A (ABI, Palo Alto, CA, USA).
3. Results
3.1. Isolation of mutants
Mutants whose growth was dependent on the presence of
plasmid carrying the wild type NIN1 gene were screened by
the colony color assay developed by Koshland et al. [20]. In
brief, strain TM1-4B [pDL120] was mutagenized with ethyl-
methane sulfonate as described by Lindegren et al. [32] and an
appropriate dilution of the mutagenized cells was spread on
YPD plates at 25‡C. Since the growth of the parental strain is
not dependent on pDL120 at 25‡C, colonies developing from
the parental strain contain red and white sectors on YPD at
25‡C. In contrast, a colony developing from a cell containing
a mutation synthetically lethal with nin1-1 displays uniformly
red on YPD at 25‡C since a strain containing such a mutation
is dependent on the presence of plasmid pDL120. Among
approximately 50 000 colonies tested, 14 uniformly red colo-
nies were obtained and subjected to further analysis. Among
them, ¢ve mutants (#14, #47, #77, #114, and #205) showed a
reproducible phenotype. Each isolate was crossed to the nin1-
1 strain (YK110). The synthetic lethality was no longer shown
in the resultant diploids, indicating that the additional muta-
tions are recessive. The trait of synthetic lethality was segre-
gated 2+:23 in every heterozygous diploid except a diploid
containing strain #14 [9]. Complementation tests between
these ¢ve mutant strains de¢ned ¢ve complementation groups,
each of which is represented by a single mutant.
To facilitate genetic analyses, pDL120 plasmid (URA3-
NIN1-ADE3) was replaced with pHN19, whose NIN1 is ex-
pressed by the GAL1 promoter [15]. Each of SUN1 and SUN2
on a multicopy plasmid (YEp24) was introduced into each of
the mutants and we examined whether SUN1 or SUN2 could
be a suppressor of the lethality. Synthetic lethality of #47 and
#77 was weakly suppressed by SUN2 on a multicopy vector
whereas that of #114 was partially suppressed by multicopy
SUN1. The fact that neither SUN1 nor SUN2 fully suppressed
the synthetic lethality indicates that they are not the genes
responsible for the synthetic lethality. So far we have suc-
ceeded in isolating three genes by exploiting #14, #47, and
#114 as hosts. We identi¢ed SEN3 in #14 [9] and CIM5 in
#47 (to be published elsewhere). In this communication, our
primary concern is with the gene identi¢ed in the #114 mu-
tant.
A YCUp4 based genomic library was introduced into the
#114 [pHN19] strain grown in YPgal and the transformation
mixture was spread on a YPGal plate to estimate the number
of total transformants and on YPD plates to recover trans-
formants. From about 7000 colonies tested, 15 positive clones
were obtained. Plasmid was recovered from each of the iso-
lates. Only one plasmid was found to contain a gene other
than NIN1 and the rest contained NIN1. The plasmid that
contained a non-NIN1 sequence was partially sequenced at




Strain Genotype Source or reference
W303D MATa/MATK leu2/- his3/- trp1/- ura3/- ade2/- can1/- [36]
W303-1B MATK leu2 his3 trp1 ura3 ade2 can1 A segregant of W303D
YK110 MATK nin1-1 leu2 his3 trp1 ura3 ade1 [17]
TM1-4B MATa nin1-1 leu2 trp1 ura3 ade2 ade3 [9]
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DNA segment cloned was derived from chromosome 4 con-
taining SON1(YDL020c) and the 5P truncated
PGM2(YDL021w) (Fig. 1A). The 3 kbp SmaI-SalI fragment
contains SON1 as a sole complete ORF and a low copy plas-
mid (YCUp4-SON1) containing this DNA segment comple-
mented the synthetic lethality of the #114 [pHN19] strain
(Fig. 1B), suggesting that SON1 is the gene responsible for
this synthetic lethality. To our surprise, the derivative of
YCUp4-SON1vRv constructed by deleting two EcoRV frag-
ments which reside within the SON1 ORF still retained the
complementation activity (Fig. 1B). To further examine
whether son1 is the gene responsible for synthetic lethality
in #114, plasmid DNA containing SON1 and URA3 was tar-
geted to the son1 locus of #114 [pHN19] and the resulting
Ura transformants were subjected to linkage analysis. The
Ura transformants were able to grow on YPD. One of these
transformants was crossed to YK110 and the diploids were
sporulated and dissected. No segregant showing synthetic le-
thality was obtained among 16 asci tested, indicating that the
mutation concerned occurred in the SON1 gene.
3.2. Synthetic lethality of son1 with other genes
The SON1 gene of W303-1B was disrupted by the one step
replacement method [33] using the son1: :HIS3 gene shown in
Fig. 1A as donor. The correct disruption was con¢rmed by
Southern hybridization (data not shown) and the resultant
disruptant was viable as described previously [21].The son1: :
HIS3 strain was crossed with each of the sen3: :URA3,
sun1: :LEU2, and cdc28-1N. In the crosses between son1
and sen3 and between son1 and cdc28-1N, every double mu-
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Fig. 1. Genetic analysis of the SON1 gene. A: The map of the SON1 locus. Arrows indicate the ORFs and their direction. Internal EcoRv
fragments were deleted from the SON1, resulting in SON1vRv. This deletion resulted in removing internal 97 amino acid residues (219^315)
and the N-terminal portion was fused to the C-terminal portion in frame. YCUp4-SON1 was constructed by inserting the 3 kbp SalI-SmaI
fragment possessing the SON1 gene into the SalI-SmaI gap of YCUp4, a CEN-ARS plasmid containing URA3 as a selective marker. The
SON1vRv gene was inserted into YCUp4, resulting in YCUp4-SON1vRv. The SON1 gene was disrupted by replacing the EcoRV fragments
within the SON1 ORF with the blunt ended fragment containing HIS3 excised from pJJ217 [37]. B: Plate test for complementation. Each
YCUp4, YCUp4-SON1, and YCUp4-SON1vRv was introduced into #114 [pHN19] and two representative transformants from each transfor-
mation experiment was streaked on YPD plate or YPGal plate which were incubated at 25‡C for 4 days. Symbols: S, SalI ; Sm, SmaI; B,
BamHI; G, BglII; Rv, EcoRV.
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tant spore was inviable or very sick, whereas, in the cross
between son1 and sun1, double mutant spores were obtained
but showed temperature sensitive growth (data not shown).
We also con¢rmed the synthetic lethality between nin1-1 and
son1: :HIS3 (data not shown). Since Sen3p, Nin1p, and
Sun1p are the regulatory subunits of the yeast 26S proteasome
and since some genes showing synthetic lethality with cdc28-
1N also encode the components of the 26S proteasome, we
examined the possibility that Son1p can be a component of
the yeast 26S proteasome.
3.3. Son1p as a component of the 26S proteasome
The 26S proteasome was partially puri¢ed from extract
prepared from W303D cells grown in YPD for 36 h at 25‡C
as described in Section 2. Fig. 2A shows the elution pattern of
FPLC on a Superose 6 column. Protease activity was assayed
for each fraction in the presence of ATP and absence of SDS
or in the presence of SDS and absence of ATP. The 26S
proteasome activity was detected in the former condition
and the 20S proteasome activity was enhanced in the latter
condition. The 26S proteasome was eluted at a position peak-
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Fig. 2. Son1p is associated with the 26S proteasome. A: Elution pattern of Superose 6 FPLC chromatography. For the protease assay, Suc-
LLVY-MCA was used as substrate. 5 Wl of the indicated fraction was added to 100 Wl reaction mixture containing 50 mM Tris-HCl, pH 7.8,
1 mM DTT, 2 mM ATP, 10 mM MgCl2, 0.1 mM Suc-LLVY-MCA (+ATP, 3SDS, solid circles) or 50 mM Tris-HCl, pH 7.8, 1 mM DTT,
5 mM EDTA, 0.02% SDS, 0.1 mM SucLLVY-MCA (3ATP, +SDS, open squares). Incubation was carried out at 37‡C for 12 min. The reac-
tion was stopped by adding 1 ml of 10% SDS. Molecular weight markers used were thyroglobulin (669 kDa), apoferritin (443 kDa), and alco-
hol dehydrogenase (150 kDa). B: Western blotting. The indicated fraction (20 Wl) was subjected to 12.5% SDS-PAGE. The proteins separated
were electrotransferred to nitrocellulose membrane ¢lter. Menbrane was probed with antibodies indicated. C: Immunoprecipitation. 20 Wl of
the peak fraction 23 of FPLC (see A) was immunoprecipitated with 20 Wl of anti-Son1p antibody conjugated to protein A-Sepharose beads
and also with non-immune rabbit IgG conjugated to protein A-Sepharose beads as control. The resulting supernatant (S) and precipitate (P)
were subjected to SDS-PAGE followed by Western blot analysis with anti-Nin1p antibody (a), anti-20S proteasome antibody (b), and anti-
Sun1p antibody (c). IP, immunoprecipitation; Blot, Western blotting.
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ing at fraction 23 with a molecular weight of 1300 kDa,
whereas the 20S proteasome eluted at position peaking at
fractions 26^27 with a molecular weight of 700 kDa (Fig.
2A). Proteins in each fraction was separated by SDS-PAGE
and analyzed by immunoblotting using anti-Son1p, anti-
TBP1, anti-Sun1p, anti-Nin1p, anti-p45, and anti-20S protea-
some antibodies. As shown in Fig. 2B, Son1p was distributed
at the 26S proteasome area overlapping with TBP1, Sun1p,
and p45. Fraction 23 was treated with anti-Son1p antibodies
and the resulting precipitate was analyzed by Western blotting
using anti-Nin1p antibody, anti-Sun1p antibody or anti-20S
proteasome antibody. As shown in Fig. 2C, Son1p was pre-
cipitated with authentic 26S proteasome components, such as
Nin1p, Sun1p and 20S proteasomes.
4. Discussion
Genetic characterization of SON1 which was identi¢ed as a
mutation showing synthetic lethality with nin1-1, which tends
to show a synthetic e¡ect with various mutations, occurred in
components of the 26S proteasome. Furthermore, we found
that Son1p is co-eluted with the yeast 26S proteasome in
Superose 6 FPLC and that Son1p was co-precipitated with
Nin1p, Sun1p, and the 20S proteasome. These genetic and
biochemical lines of evidence indicate that Son1p is a
component of the yeast 26S proteasome. The SON1 gene
can encode 531 amino acid residues. Substitution of a DNA
segment encoding 97 amino acid residues from amino acid
219 to amino acid 315 by the HIS3 marker destroyed the
function of the SON1 whereas a SON1 derivative with an
internal deletion of the 97 amino acid residues was found to
be functional as SON1 (Fig. 1). This result suggests that two
acidic regions covered by the deletion exert no essential role
and that the C-terminal region is important for the Son1p
function.
SON1 was ¢rst identi¢ed [21] as a suppressor of temper-
ature sensitive growth of nlp1-1 (sec63-101). The sec63-101
mutant showed temperature sensitive growth and mislocalized
nuclear proteins. son1 suppressed the temperature sensitivity
of sec63-101 but not the defect in nuclear transport. Suppres-
sion by son1 was allele speci¢c and the son1 mutation alone
resulted in a defect in nuclear transport. In this context, it
should be noted that the SEN3 encoding the largest subunit
of the 26S proteasome, a deletion of which was synthetically
lethal with son1, has a function in protein transport to the
nucleus [9]. Genetic interaction between son1 and sen3, along
with the fact that both Son1p [21] and Sen3p [34] localize in
nucleus, is consistent with the idea that both genes work in
nuclear transport. Recently, Xu and Kurjan [23] isolated son1
and sen3 mutants as suppressors of the mating defect dis-
played by the gpa1val50 mutant. They showed that son1 and
sen3 are synthetically lethal. They explained their genetic re-
sults by assuming that some positive factor(s) might be in-
volved in a mating pathway and that these factor(s) might
be degraded by the ubiquitin-proteasome pathway.
Involvement of Son1p in protein degradation was directly
indicated by Johnson et al. [22] ; they identi¢ed son1 as a
mutant (ufd5) defective in degradation of ubiquitin-L-galacto-
sidase fusion protein which is degraded by the 26S proteasome
after polyubiquitination. The son1/ufd5 mutant did polyubiq-
uitinate ubiquitin-L-galactosidase but did not degrade it.
Thus, it is likely that SON1 protein is needed for the protease
activity, consistent with our present result that SON1 is a
component of the 26S proteasome. How then can the suppres-
sion of sec63-101 by son1 be explained? A simple explanation
is that Sec63-101p became unstable by the mutation and that
its instability was cancelled by a son1 mutation. However, this
explanation is unlikely because Nelson et al. [21] reported that
Sec63-101p showed the same stability in the presence or ab-
sence of Son1p. Another explanation is that the sec63-101
mutation may destabilize protein(s) interacting with Sec63p,
instead of itself. In this hypothesis, we assume that Sec63p
interacts with protein(s) which are stabilized by making a
complex with Sec63p. This interaction may be lost in the
sec63-101 mutant, rendering the interacting protein accessible
to the 26S proteasome. The stability of the protein(s) might be
improved by the son1 mutation which reduces protease activ-
ity of the 26S proteasome. Actually, Brodsky and Schekman
[35] demonstrated that Sec63p forms a complex with Bip in
the endoplasmic reticulum lumen and with Sec66p and Sec67p
in the cytosol. These factors or other(s) interacting with
Sec63p could be a target for degradation by the 26S protea-
some.
A counterpart of SON1 in other organisms is not known.
Since not all the subunits of the mammalian 26S proteasome
are known at present, there is a possibility that a SON1 coun-
terpart may be found in future. Since Son1p is not essential,
the 26S proteasome without Son1p is able to execute the 26S
proteasome functions at an ordinary temperature but it is
needed for degradation of a set of proteins, such as ubiqui-
tin-L-galactosidase and a putative protein interacting with
Sec63p or involved in the mating pathway. This result sug-
gests that isoforms of the 26S proteasome exist and that each
of them exerts a respective degradative function in various
facets of cellular processes.
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